BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26987766)

  • 1. Prostate-specific antigen testing rates and referral patterns from general practice data in England.
    Moss S; Melia J; Sutton J; Mathews C; Kirby M
    Int J Clin Pract; 2016 Apr; 70(4):312-8. PubMed ID: 26987766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK.
    Brett J; Watson E; Hewitson P; Bukach C; Edwards A; Elwyn G; Austoker J
    BMC Fam Pract; 2005 Jun; 6(1):24. PubMed ID: 15946386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepancies between guidelines and clinical practice regarding prostate-specific antigen testing.
    Hamoen EH; Reukers DF; Numans ME; Barentsz JO; Witjes JA; Rovers MM
    Fam Pract; 2013 Dec; 30(6):648-54. PubMed ID: 24107269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: an ecological study.
    Hjertholm P; Fenger-Grøn M; Vestergaard M; Christensen MB; Borre M; Møller H; Vedsted P
    Int J Cancer; 2015 Jan; 136(2):435-42. PubMed ID: 24905402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSA testing in general practice.
    Hodgson F; Obertová Z; Brown C; Lawrenson R
    J Prim Health Care; 2012 Sep; 4(3):199-204. PubMed ID: 22946067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doctors' approaches to PSA testing and overdiagnosis in primary healthcare: a qualitative study.
    Pickles K; Carter SM; Rychetnik L
    BMJ Open; 2015 Mar; 5(3):e006367. PubMed ID: 25783420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
    Jønler M; Eddy B; Poulsen J
    Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study.
    Young GJ; Harrison S; Turner EL; Walsh EI; Oliver SE; Ben-Shlomo Y; Evans S; Lane JA; Neal DE; Hamdy FC; Donovan JL; Martin RM; Metcalfe C
    BMJ Open; 2017 Oct; 7(10):e017729. PubMed ID: 29084797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PSA testing dilemma: GPs' reports of consultations with asymptomatic men: a qualitative study.
    Clements A; Watson E; Rai T; Bukach C; Shine B; Austoker J
    BMC Fam Pract; 2007 Jun; 8():35. PubMed ID: 17593306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study.
    Melia J; Moss S; Johns L;
    BJU Int; 2004 Jul; 94(1):51-6. PubMed ID: 15217430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities.
    Williams N; Hughes LJ; Turner EL; Donovan JL; Hamdy FC; Neal DE; Martin RM; Metcalfe C
    BJU Int; 2011 Nov; 108(9):1402-8. PubMed ID: 21481132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen testing among the elderly in community-based family medicine practices.
    Hudson SV; Ohman-Strickland P; Ferrante JM; Lu-Yao G; Orzano AJ; Crabtree BF
    J Am Board Fam Med; 2009; 22(3):257-65. PubMed ID: 19429731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners.
    Drummond FJ; Carsin AE; Sharp L; Comber H
    BMC Fam Pract; 2009 Jan; 10():3. PubMed ID: 19138385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of prostate cancer screening in a UK region.
    Gavin A; McCarron P; Middleton RJ; Savage G; Catney D; O'Reilly D; Keane PF; Murray LJ
    BJU Int; 2004 Apr; 93(6):730-4. PubMed ID: 15049981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPs views and understanding of PSA testing, screening and early detection; survey.
    Sutton J; Melia J; Kirby M; Graffy J; Moss S
    Int J Clin Pract; 2016 May; 70(5):389-95. PubMed ID: 27121158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSA testing in general practice.
    Little B; Ho KJ; Gormley G; Young M
    Prostate Cancer Prostatic Dis; 2003; 6(2):154-8. PubMed ID: 12806375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for prostate cancer in New Zealand general practice.
    Zuzana O; Ross L; Fraser H; Charis B; Alistair S; Leanne T; Michael H; Peter G
    J Med Screen; 2013 Mar; 20(1):49-51. PubMed ID: 23612467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
    Bunting PS; Goel V; Williams JI; Iscoe NA
    CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostate cancer screening using prostate-specific antigen: The views of general and laboratory physicians].
    Giménez N; Filella X; Gavagnach M; Allué JA; Pedrazas D; Ferrer F;
    Semergen; 2018 Sep; 44(6):409-419. PubMed ID: 29574008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.